William Blair Initiates Coverage On Enliven Therapeutics with Outperform Rating
Benzinga Newsdesk 2 months ago
NewsInitiationAnalyst Ratings
William Blair analyst Andy Hsieh initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.
William Blair analyst Andy Hsieh initiates coverage on Enliven Therapeutics (NASDAQ:ELVN) with a Outperform rating.